CocrystalPharmaInc.jpg
Cocrystal Pharma Announces $10.0 Million Bought Deal Offering
26. August 2020 17:35 ET | Cocrystal Pharma, Inc.
BOTHELL, WA, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...